The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...

A man succumbed to injuries after the metallic chain around his neck caused him to be pulled into an active MRI machine at ...

It's important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about ...

Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at healing centers in the state is not covered by insurance.

Trump officials embrace psychedelic drugs after FDA setback, promising medical approvals within 12 months despite scientific concerns.

Last week, the United States Food and Drug Administration (FDA) and A.P. Deauville issued a voluntary recall for over 67,000 ...

FDA outlines both short-term and long-term goals within the letter. In the short term, FDA plans to create a “centralized, ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

The FDA has issued a voluntary recall of over 67,000 cases of Power Stick roll-on deodorants due to deviations from ...

A.P. Deauville recalled 67,000 cases of Power Stick deodorant on July 10, 2025, for FDA-noted cGMP violations, affecting ...

On July 14, 2025, the U.S. Food and Drug Administration (FDA) announced an extension to the public comment period for its ...